March 31, 2021
Number of shares and votes in Oncopeptides
Media
March 26, 2021
Nordic Nanovector ASA publishes 2020 Annual Report
March 25, 2021
Fusion Pharmaceuticals Announces Fourth Quarter 2020 Financial Results And Business Update
March 25, 2021
Nordic Nanovector ASA – Commencement of the subscription period in the repair offering
March 23, 2021
Orexo publishes Annual Report for 2020
March 22, 2021
Spruce Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Recent Corporate Updates
March 22, 2021
Nordic Nanovector ASA: Prospectus approved
March 22, 2021
Oncopeptides announces that PEPAXTO® is included in new Multiple Myeloma guidelines of National Comprehensive Cancer Network®
March 22, 2021
Nordic Nanovector ASA – Resolution to increase the share capital in connection with the repair offering and terms of the repair offering
March 20, 2021
Strongbridge Biopharma plc Presents Detailed Results from Pivotal Phase 3 LOGICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 2021 Annual Meeting of the Endocrine Society (ENDO)